• May 22, 2018
    Dune Medical sets the stage for growth, naming Alan Bond Chief Financial Officer
    May 17, 2018 (Alpharetta, Ga.) Dune Medical Devices has appointed Alan Bond as Chief Financial Officer. Bond is a veteran financial executive with an extensive record of developing and implementing strategy, and driving revenue and profitability in the medical device industry. Bond joins the Dune Atlanta office after years with McKesson and Given Imaging. “Alan has experience in both large and small organizations during times where the companies were undergoing significant strategic changes and acquisitions,” says Lori Chmura, CEO of...
  • May 1, 2018
    New research shows MarginProbe reduces re-excision rates for breast conserving surgery by 61%, giving renewed hope to breast cancer patients
    A study recently published in the American Journal of Surgery demonstrates that proper use of Dune Medical Devices’ intraoperative margin assessment device, MarginProbe, results in a significant identification of positive margins and a resulting reduction in the re-excision rate for breast conserving surgery - the standard option for patients with early-stage breast cancer. The research led by Amanda Kupstas, MD, Warda Ibrar, MD, D. Richard Hayward, PhD, Daniel Ockner, MD, Cheryl Wesen, MD, FACS, and Jeffrey Falk, MD, FACS, of...
  • Apr 19, 2018
    Collectively improving the standard of breast cancer treatment at ASBrS 2018
    About the American Society of Breast Surgeons (ASBrS) In the organization’s own words, “The American Society of Breast Surgeons, the primary leadership organization for general surgeons who treat patients with breast disease, is committed to continually improving the practice of breast surgery by serving as an advocate for surgeons who seek excellence in the care of breast patients. This mission is accomplished by providing a forum for the exchange of ideas and by promoting education, research, and the development of...
  • Apr 2, 2018
    WWMT Doc Talk: A new tool and a new technique for battling breast cancer
    Dr. Daniel Barnas, a surgeon at Borgess Medical Center, talks about new techniques for breast cancer surgery. (WWMT/Courtesy of Borgess Health) “The national average for re-excision surgery after a lumpectomy is 22 percent, Dr. Daniel Barnas said. When this tool is used, he said, that percentage drops well below the national average.” Recently, Dr. Daniel Barnas, MD, Breast Surgeon at Borgess Medical Center and advocate of the MarginProbe was interviewed by WWMT during a segment called “Doc Talk.” During the interview...
  • Mar 19, 2018
    Dune Medical Named a Top 10 Innovative Technology Company
    The Technology Association of Georgia (TAG), the state’s leading association dedicated to the promotion and economic advancement of Georgia’s technology industry, has chosen Dune Medical as one of its Top 10 Innovative Technology Companies in Georgia. TAG will recognize this group at The Summit 2018 this week. The “Top 10” most innovative technology companies are chosen from among TAG’s "Top 40" 2018 list and were chosen based on a number of criteria, including: degree of innovation; scope and financial...